Source link : https://www.newshealth.biz/health-news/obinutuzumab-for-lupus-nephritis-boosts-complete-remissions/
(MedPage Today) — Adding a monoclonal antibody approved for blood cancer indications to standard therapy for adults with active lupus nephritis outperformed standard therapy alone in a phase III trial. In the REGENCY study, 46.4% of patients… Source link : https://www.medpagetoday.com/rheumatology/lupus/114139 Author : Publish date : 2025-02-07 22:37:22 Copyright for syndicated content belongs to the […]
Author : News Health
Publish date : 2025-02-07 22:37:22
Copyright for syndicated content belongs to the linked Source.